With a career that has spanned decades and crossed the barriers of academia and industry, Professor Sir John Bell is well-placed to discuss the state of the biopharma industry and share his concerns about the future of the sector in light of current geopolitical events.
A Canadian immunologist and geneticist, Sir John holds the Regius Chair of Medicine at the University of Oxford. He was...